Generics 21

Originals

Biosimilars

Medical devices

Nutraceuticals

Filters

Teriflunomide manufacturers

21 products found

Filters

21 products found

teriflunomide

Tablets, film coated 14 mg

Dossier type
EU CTD
Dossier status
Ready to file
Country of origin
European Union
GMP approvals
EU GMP
Comments
Ref: Aubagio®
Manufacturer #252

Manufacturer usually replies in 2 days

teriflunomide

Tablets, film coated 14 mg

Dossier type
EU CTD
Dossier status
Ready to file
Country of origin
European Union
GMP approvals
EU GMP
Comments
EU MA’s Granted
Manufacturer #21467

Manufacturer usually replies in 5 days

teriflunomide

Tablets, film coated 14 mg

Dossier type
EU CTD
Dossier status
Ready to file
Country of origin
European Union
GMP approvals
EU GMP
Manufacturer #519

Manufacturer usually replies in 6 days

teriflunomide

Tablets, film coated 14 mg, 7 mg

Dossier type
EU CTD
Dossier status
Ready to file
Country of origin
European Union
GMP approvals
EU GMP
Available for
Licensing with supply, Technology transfer
Manufacturer #260
Pharmaceutical manufacturer operating in the EU for 50+ years. Activities include scientific development, manufacturing, out-licensing, marketing, and distribution of high-quality generic medicines. The company owns several production facilities that all comply with EU GMP requirements. Key dosage forms include conventional solids, cytostatic injectables, and cytostatic orals. The company holds an in-house R&D and Intellectual property business unit, as well as a regulatory affairs team that prepares CTD dossiers and maintains direct contact with regulatory agencies worldwide. The portfolio includes more than three thousand MA sets approved in the EU while hundreds of MA are in progress. Key therapy lines are cardiovascular, CNS, diabetes, immunology, oncology, and more. The company is active in nearly 100 countries worldwide, selling its products in Africa, Asia, Australia, Europe, LATAM, and the Middle East.

Manufacturer usually replies in 12 days

teriflunomide

Tablets, film coated 7 mg, 14 mg

Dossier type
EU CTD
Dossier status
Under development
Country of origin
European Union
GMP approvals
EU GMP
Unavailable markets
Vietnam
Comments
Dossier availability date: Q1 2025
Manufacturer #437
A pharmaceutical manufacturer based in the EU that is active in 40+ countries selling its products in Europe, North America, LATAM, Africa, Middle East, and Asia for 40+ years. Main therapeutics areas include the nervous system, cardiometabolic, and women’s health. The company's production lines are GMP-compliant. The main dosage forms are solid, semi-solid, liquid, and suspension. The company owns branches in the EU, Africa, and LATAM.

Manufacturer usually replies in 10 days

teriflunomide

Tablets, film coated 7 mg, 14 mg

Dossier type
EU CTD
Dossier status
Ready to file
Country of origin
Iceland
GMP approvals
EU GMP
Manufacturer #28915

Manufacturer usually replies in 16 days

teriflunomide

Tablets 14 mg

Dossier type
EU CTD
Dossier status
Ready to file
Country of origin
Canada
GMP approvals
EU GMP, Canada
Comments
Reference product : Aubagio (Genzyme)
Manufacturer #278

The company has become a prominent partner of the pharmacy community in North America, with the fastest rising market share among generic leaders. It can provide best-in-class supply reliability thanks to production capacity. In more than 50 countries, it's available locally or through corporate partnerships. R&D expenditures range from $40 million to $50 million per year. They are dedicated to maintaining a customer satisfaction rate of over 95% by continuously enhancing supply chain efficiency.

Manufacturer usually replies in 7 days

teriflunomide

Tablets, film coated 14 mg, 7 mg

Dossier type
EU CTD
Dossier status
Ready to file
Country of origin
India
GMP approvals
EU GMP
Unavailable markets
Costa Rica
Comments
Reference product: Aubagio (Sanofi)
Manufacturer #1338

Manufacturer usually replies in 7 days

teriflunomide

Tablets 14mg

Dossier type
EU CTD
Dossier status
Under development
Country of origin
Turkey
GMP approvals
EU GMP
Manufacturer #281
It is a leading European pharmaceutical firm that strives to create a powerful global brand with innovative goods and services, as well as bold and pioneering activities, by working passionately to heal the lives they touch. The business was founded in the 1900s. In the interest of public health and the national economy, the firm launched the project to promote public awareness about the unintentional use of medications.

Manufacturer usually replies in 8 days

teriflunomide

Tablets 14mg Q1/2019

Dossier type
CTD
Dossier status
Under development
Country of origin
Argentina
GMP approvals
PICS
Unavailable markets
Costa Rica
Manufacturer #678
It is situated in the southern part of South America. It is committed to excellence and continuous improvement. They have a production plant for the manufacturing of high value-added products like the treatment of HIV-AIDS and neurodegenerative and cardiovascular diseases.

Manufacturer usually replies in 3 days

teriflunomide

Tablets, film coated 14 mg

Dossier type
CTD
Dossier status
Ready to file
Country of origin
Turkey
GMP approvals
EU GMP, PICS
Manufacturer #2760

Manufacturer usually replies in 5 days

teriflunomide

Tablets, immediate release (IR) 7 mg, 14 mg

Dossier type
CTD
Dossier status
Ready to file
Country of origin
India
GMP approvals
EU GMP
Manufacturer #17331

Manufacturer usually replies in 8 days

teriflunomide

Tablets, film coated 14 mg

Dossier type
EU CTD
Dossier status
Ready to file
Country of origin
Turkey
GMP approvals
Turkey
Comments
Reference Product : Aubagio
Manufacturer #2748
It is a privately held pharmaceutical company based in southeast Europe that was established in the 1990s to import and introduce pharmaceutical items into medicine. The company began by importing hemophilia and intensive care supplies, as well as immunoglobulin-containing items. To suit market demands, the company has added additional dermatological, cardiological, urological, and surgical goods to its portfolio since then. They now offer a diverse product line that includes not only prescription but also OTC, medical gadgets, and dermo-cosmetics.

Manufacturer usually replies in 7 days

teriflunomide

Tablets, film coated 14mg

Dossier type
CTD
Dossier status
Ready to file
Country of origin
Argentina
GMP approvals
Argentina, Brazil, Pakistan, Paraguay, Peru, Uruguay, WHO, PICS
Manufacturer #16112

Manufacturer usually replies in 6 days

teriflunomide

Tablets, film coated 14mg

Dossier type
CTD
Dossier status
Ready to file
Country of origin
Argentina
GMP approvals
Argentina
Manufacturer #16199
One of the largest and biggest names in the pharmaceutical industry. The company has a network all across the globe. They are known to be partnering with similar companies for a very long time.

Manufacturer usually replies in 9 days

teriflunomide

Tablets, film coated 14 mg

Dossier type
EU CTD
Dossier status
Ready to file
Country of origin
India
GMP approvals
EU GMP
Manufacturer #385
A pharmaceutical manufacturer based in the EU that has been active in 60+ countries selling its products in Europe, North America, LATAM, MENA, Africa, and Asia for 60+ years. Key production lines are Rx and nutraceuticals. The company's production lines are EU GMP-compliant.

Manufacturer usually replies in 11 days

teriflunomide

Tablets, film coated 7 mg, 14 mg

Dossier type
US CTD
Dossier status
Ready to file
Country of origin
India
GMP approvals
FDA
Unavailable markets
Colombia , Iran , Vietnam
Available for
Licensing with supply
Comments
Indication: Multiple Sclerosis; Status: MA granted (US), Dossier available (EU)
Manufacturer #385
A pharmaceutical manufacturer based in the EU that has been active in 60+ countries selling its products in Europe, North America, LATAM, MENA, Africa, and Asia for 60+ years. Key production lines are Rx and nutraceuticals. The company's production lines are EU GMP-compliant.

Manufacturer usually replies in 11 days

teriflunomide

Tablets 14 mg

Dossier type
CTD
Dossier status
Ready to file
Country of origin
Turkey
GMP approvals
PICS
Manufacturer #13095

Manufacturer usually replies in 5 days

teriflunomide

Tablets 14 mg, 7 mg

Dossier type
CTD
Dossier status
Ready to file
Country of origin
India
GMP approvals
WHO
Manufacturer #17753

Manufacturer usually replies in 10 days

teriflunomide

Tablets, buccal 7mg, 14 mg

Dossier type
CTD
Dossier status
Ready to file
Country of origin
China
GMP approvals
China
Unavailable markets
United States
Available for
Technology transfer
Manufacturer #32252

Want to view all 21 products? Create your free account today!

Teriflunomide Manufacturers

Teriflunomide is a pyrimidine synthesis inhibitor with immunomodulatory properties and anti-inflammatory used for curing patients with the relapsing-remitting form of multiple sclerosis. This medical remedy is the active metabolite of leflunomide, and this substance acts as an immunomodulatory agent by inhibiting pyrimidine synthesis. Warnings: Follow all Instructions on your medicine package and label. It is wise to tell your healthcare providers about all your medical allergies, illnesses, and all medicines you use. Before taking this medicine: You should not use Teriflunomide if you are allergic to it Teriflunomide may also is used for purposes that may not have been listed in this medication guide.

How to use Teriflunomide?

Read the Teriflunomide Guide and, if available, the Patient Information Leaflet that will be provided by your pharmacist before you start taking Teriflunomide. If you have any questions related to Teriflunomide, ask your pharmacist or doctor. The exact mechanism of Teriflunomide by which this drug acts in MS is not known. After oral administration of this pharmaceutical drug, maximum plasma concentrations are reached, on average, in 1-4 hours.

How much money does Teriflunomide cost?

It is obtainable in generic and brand versions. It is not covered by most Medicare and insurance plans, but pharmacy coupons can help balance the price. The cost for Teriflunomide oral tablet 7 mg is around $7,862 for a supply of 28. Prices may vary on the pharmacy you visit.

Navigating our pharmaceutical marketplace

Being a global B2B pharmaceutical online marketplace, Pipelinepharma is structured to simplify pharmaceutical deals by providing you with an intuitive interface that is easy to engage with. The selection of Teriflunomide offerings can be narrowed down with the use of filters and easily weighed against one another according to medication prices and commercial terms. The advanced filters help you filter out the countries for Teriflunomide manufacturers and Teriflunomide suppliers that you are looking for. These also enable you to check the dossier status of Teriflunomide, and the GMP approvals of the different variants of Teriflunomide. Also, each manufacturer or supplier product description contains essential information about Teriflunomide including clinical data, stability zones, countries where Teriflunomide is already registered in. Manufacturers also have special, and delivery terms.

Establishing commercial ties

If you are a pharmaceutical licensing company or a distributor you can enter into deals or negotiations over Ivermectin offers with manufacturing companies after completing the free registration process and joining our online marketplace. This helps to ensure that you conclude the pharmaceutical deal at a reasonable cost and achieve the best cost/benefit ratio for your company while bypassing lengthy sourcing, negotiation, and ordering process. Once you have finalized a deal, you can look forward to a long-lasting business relationship with the manufacturers or suppliers. This way, the marketplace allows you as a distributor to skip the process of shortlisting product manufacturers every time you are looking for in-licensing or distribution deals.

Quality Assurance

To keep up to the quality standards other than Good Manufacturing Practice approvals that Ivermectin manufacturers have, we qualify their companies before they are onboarded on the platform. This allows us to screen Ivermectin manufacturers for the quality of the pharmaceutical products’ dossiers and protect against the risk of possible malpractices.